THE US Food and Drug Administration (FDA) last week released seven draft, revised draft and final guidance documents on everything from how to develop new drugs to treating early Alzheimer's, Duchenne Muscular Dystrophy and acute migraines and more.
CLICK HERE for access.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Feb 18
